Anne Wojcicki, CEO of the Google-backed gene testing company 23andme, has temporarily thrown in the towel to the Food and Drug Administration.
A letter posted on her Mountain View company’s website said it has stopped its health-related genetic tests for consumers to comply with the federal agency’s order to stop marketing the product until it gets FDA approval.
However, the company said customers who bought the service before Nov. 22, when the FDA issued its order, will still have access to their health-related test results.
It also noted that it’s still providing “ancestry-related genetic tests and raw genetic data, without 23andMe’s interpretation.”
In addition, it said, “23andMe may provide health-related results in the future, dependent upon FDA marketing authorization.”
Photo by Peter DaSilva, The New York Times